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(57) ABSTRACT 
The invention relates to methods for identifying compounds 
Which affect cellular stress. In particular, the method relates 
to identifying compounds Which inhibit protein advanced 
glycation end product formation, Where the compounds are 
carbonyl scavengers Which inhibit the formation. The assay 
involves combing the substance of interest With histone H1 
and ADP-ribose, and then measuring ?uorescence and pro 
tein cross linking. Various inhibitors of protein AGE glyca 
tion have been identi?ed, using this assay. 
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Fluorescence yield of various sugars and histone H1 over 7 days 
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